OHB's €1bn IRIS² Breakthrough Is Being Buried Under the Weight of Its Own Shareholder Overhaul

OHB's €1B SES deal fails to lift shares, down 30% in month amid dilutive capital increase and free-float expansion.

The disconnect between OHB's operational trajectory and its share price has rarely been starker. The Bremen-based space group signed a roughly €1 billion contract with satellite operator SES last Tuesday to develop and build 18 satellite platforms for medium-Earth orbit as part of Europe's IRIS² secure communications programme — precisely the kind of headline-grabbing win that should galvanise investor confidence. Instead, the stock has spent the intervening days sliding further into the red, closing Wednesday at €177.60, down 2.9 percent on the day and 5.9 percent lower on the week. Over the past month, the equity has shed a bruising 30 percent.

The market's refusal to reward good news stems less from the order book than from the company's capital structure — a story that began unfolding in late June when OHB pushed through a heavily dilutive rights issue. The board, with supervisory board approval, resolved on 22 June to issue up to 1,702,480 new shares, equivalent to 8.86 percent of share capital, at a subscription price of €300 apiece. That priced the maximum gross proceeds at €510.7 million. The Fuchs family vehicles — FFS, VOLPAIA and Martello Value — alongside KKR-affiliated Orchid Lux, waived their subscription rights, setting the stage for the free float to balloon from roughly 6 percent to as much as 26 percent.

The announcement itself, made on 15 June, knocked around ten percent off the share price before a single new share had even traded. When the first tranche of roughly 1.6 million shares began trading on 26 June, Orchid Lux simultaneously offloaded a substantial chunk of its approximate 29 percent stake via an upsized bookbuilding at that same €300 price point. By early July, OHB confirmed the second tranche had also been completed. The net proceeds are earmarked for production capacity expansion, strategic acquisitions, launch vehicles and future programmes — sensible uses of capital, but the dilution inflicted on existing holders has left a sour taste that no amount of operational polish seems to erase.

Thursday brought a measure of relief, with the shares climbing 2.6 percent to €182.20, though traders attribute the bounce to technical stabilisation rather than any fresh catalyst. The move unfolds against a grim backdrop: the stock trades roughly 75 percent below its 52-week high of €688.00 reached in May, and sits around 28 percent under its 50-day moving average of €245.91. The scale of the drawdown reflects not merely the capital increase but also the departure of a major anchor shareholder, a combination that has left the market struggling to find its footing since OHB's promotion to the SDAX just over three weeks ago.

The IRIS² contract itself carries genuine strategic heft. SES, which leads the medium-Earth-orbit segment within the SpaceRISE consortium alongside Eutelsat and Hispasat, directly commissioned OHB for the work — the first major award since the programme's implementation phase officially kicked off in early August. Each platform weighs approximately 2.6 tonnes and delivers around 15 kilowatts of power. First satellite launches are pencilled in for 2029, with data transmission slated to begin in 2030. Brussels envisions a full constellation of 348 satellites across low and medium Earth orbits, positioning OHB within a long-term pipeline that extends well beyond the current decade.

For now, though, the technical picture dominates the narrative. Tuesday's session illustrated the dynamic painfully well: even as the SDAX softened into the close, OHB came under particularly aggressive selling pressure in the afternoon, the market's gaze fixed firmly on the swollen share count and the reshuffled shareholder register rather than the freshly signed contract. Whether the expanded free float eventually matures into a stability factor remains an open question — one that will only be answered once trading settles after this transitional period. Until then, investors face a schizophrenic reality: a company delivering tangible proof of its centrality to European space strategy, attached to a stock that chart technicians would still describe as deeply wounded.